QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
Free Trial

Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ING Groep stock logo
ING
ING Groep
$16.23
+1.2%		$15.09
$11.78
▼
$17.18
$60.48B1.583.09 million shs726,911 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$123.89
+0.9%		$126.36
$75.56
▼
$138.28
$555.96B0.414.83 million shs1.02 million shs
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ING Groep stock logo
ING
ING Groep
+1.07%-3.69%+1.78%+14.62%+20.29%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-1.44%-2.11%-6.54%+14.78%+197.55%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ING Groep stock logo
ING
ING Groep
3.0468 of 5 stars		0.03.03.30.02.30.03.1
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.7774 of 5 stars		1.45.02.50.02.50.03.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ING Groep stock logo
ING
ING Groep
N/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.75
Moderate Buy$133.607.84% Upside

Current Analyst Ratings

Latest NVO, ING, WHK, BBSN, and RNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$160.00
4/12/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageOutperform$163.00
4/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$160.00
3/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$160.00
2/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$140.00
2/14/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$140.00
2/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Price TargetOverweight ➝ Overweight$120.00 ➝ $140.00
1/23/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageOverweight$120.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ING Groep stock logo
ING
ING Groep
$24.43B2.48$2.37 per share6.86$16.16 per share1.00
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$33.71B16.49$3.00 per share41.36$3.45 per share35.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ING Groep stock logo
ING
ING Groep
$4.48B$2.217.347.692.8232.29%13.36%0.72%5/9/2024 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$12.15B$2.7145.8030.292.0836.03%90.36%29.18%5/2/2024 (Estimated)

Latest NVO, ING, WHK, BBSN, and RNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/1/2024Q4 2023
ING Groep stock logo
ING
ING Groep
$0.49$0.48-$0.01$0.48$6.15 billion$5.82 billion
1/31/2024Q4 2023
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.66$0.71+$0.05$0.71$9.14 billion$9.51 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ING Groep stock logo
ING
ING Groep
$0.694.25%N/A31.22%1 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.331.07%+16.52%49.17%1 Years

Latest NVO, ING, WHK, BBSN, and RNT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/7/2024
ING Groep stock logo
ING
ING Groep
Semi-Annual$0.69706.8%4/24/20244/25/20245/10/2024
1/31/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Semi-Annual$0.66400.9%3/22/20243/25/20244/2/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ING Groep stock logo
ING
ING Groep
2.24
1.12
1.12
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.19
0.82
0.64

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ING Groep stock logo
ING
ING Groep
4.49%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
ING Groep stock logo
ING
ING Groep
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ING Groep stock logo
ING
ING Groep
46,0003.73 billionN/AOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
63,3704.49 billion4.48 billionOptionable

NVO, ING, WHK, BBSN, and RNT Headlines

SourceHeadline
Got $500? 3 Healthcare Stocks to Buy and Hold ForeverGot $500? 3 Healthcare Stocks to Buy and Hold Forever
fool.com - April 19 at 8:15 AM
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares HigherHow The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
finance.yahoo.com - April 18 at 7:28 PM
Calamos Advisors LLC Reduces Position in Novo Nordisk A/S (NYSE:NVO)Calamos Advisors LLC Reduces Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 18 at 5:29 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Down 1.1%Novo Nordisk A/S (NYSE:NVO) Stock Price Down 1.1%
marketbeat.com - April 18 at 2:47 PM
Cantor Fitzgerald Reiterates "Overweight" Rating for Novo Nordisk A/S (NYSE:NVO)Cantor Fitzgerald Reiterates "Overweight" Rating for Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 18 at 10:35 AM
Novo Nordisk Foundations SVP of Natural & Technical Sciences Discusses the Future of Quantum Sensing in Clinical ResearchNovo Nordisk Foundation's SVP of Natural & Technical Sciences Discusses the Future of Quantum Sensing in Clinical Research
pharmexec.com - April 18 at 9:28 AM
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, NovoMetsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
biopharmadive.com - April 18 at 9:28 AM
Democratic senators demand answers on Novo Nordisk’s discontinued insulinDemocratic senators demand answers on Novo Nordisk’s discontinued insulin
thehill.com - April 17 at 7:27 PM
Hikari Power Ltd Sells 22,350 Shares of Novo Nordisk A/S (NYSE:NVO)Hikari Power Ltd Sells 22,350 Shares of Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 17 at 1:47 PM
Novo Nordisk A/S (NYSE:NVO) Trading Down 0.4%Novo Nordisk A/S (NYSE:NVO) Trading Down 0.4%
marketbeat.com - April 17 at 12:42 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Down 0.3%Novo Nordisk A/S (NYSE:NVO) Stock Price Down 0.3%
marketbeat.com - April 16 at 2:35 PM
Main Street Research LLC Lowers Holdings in Novo Nordisk A/S (NYSE:NVO)Main Street Research LLC Lowers Holdings in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 16 at 2:25 PM
3 Pharma Stocks That Are Money-Printing Machines in 20243 Pharma Stocks That Are Money-Printing Machines in 2024
investorplace.com - April 15 at 5:51 PM
Novo Nordisk A/S (NYSE:NVO) Trading 0.8% Higher Novo Nordisk A/S (NYSE:NVO) Trading 0.8% Higher
marketbeat.com - April 15 at 3:37 PM
How to Invest in Novo Nordisk (NVO)How to Invest in Novo Nordisk (NVO)
fool.com - April 15 at 2:29 PM
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
globenewswire.com - April 15 at 1:39 PM
Novo Nordisk and Eli Lilly weight loss drugs may not be a silver bullet, but they have huge potential, says leading US bankNovo Nordisk and Eli Lilly weight loss drugs may not be a silver bullet, but they have huge potential, says leading US bank
proactiveinvestors.co.uk - April 15 at 8:46 AM
Novo Nordisk A/S - share repurchase programmeNovo Nordisk A/S - share repurchase programme
globenewswire.com - April 15 at 8:43 AM
Novo Nordisk Arms Wegovy to Be a Triple ThreatNovo Nordisk Arms Wegovy to Be a Triple Threat
marketbeat.com - April 15 at 7:30 AM
Novo Nordisk Arms Wegovy to Be a Triple Threat Novo Nordisk Arms Wegovy to Be a Triple Threat
marketbeat.com - April 15 at 7:30 AM
Novo Nordisk A/S (NYSE:NVO) Shares Sold by Capital Advisors Inc. OKNovo Nordisk A/S (NYSE:NVO) Shares Sold by Capital Advisors Inc. OK
marketbeat.com - April 14 at 11:41 AM
BMO Capital Markets Begins Coverage on Novo Nordisk A/S (NYSE:NVO)BMO Capital Markets Begins Coverage on Novo Nordisk A/S (NYSE:NVO)
americanbankingnews.com - April 14 at 4:44 AM
Novo Nordisk A/S (NYSE:NVO) Stock Price Up 0%Novo Nordisk A/S (NYSE:NVO) Stock Price Up 0%
americanbankingnews.com - April 14 at 3:54 AM
Granite Bay Wealth Management LLC Acquires 26,055 Shares of Novo Nordisk A/S (NYSE:NVO)Granite Bay Wealth Management LLC Acquires 26,055 Shares of Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 13 at 5:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ING Groep logo

ING Groep

NYSE:ING
ING Groep N.V. provides various banking products and services in the Netherlands, Belgium, Germany, rest of Europe, and internationally. It operates through five segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, and Wholesale Banking. The company accepts current and savings accounts. It also offers business lending products; SME loans; consumer lending products, such as residential mortgage loans and other consumer lending loans; and mortgages. In addition, the company provides working capital solutions; debt and equity market solutions; various loans; payments; and cash management, trade and corporate finance, and treasury services, as well as savings, investment, insurance, and digital banking services. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Novo Nordisk A/S logo

Novo Nordisk A/S

NYSE:NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.